Have a personal or library account? Click to login
The influence of intimate hygiene on vaginal microbiota and health Cover

The influence of intimate hygiene on vaginal microbiota and health

Open Access
|Apr 2024

References

  1. Vandegrift R, Bateman AC, Siemens KN, Nguyen M, Wilson HE, Green JL, Van Den Wymelenberg KG, Hickey RJ. Cleanliness in context: reconciling hygiene with a modern microbial perspective. Microbiome. 2017;5:76.
  2. Chen Y, Bruning E, Rubino J, Eder SE. Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage. Womens Health (Lond). 2017;13:58–67.
  3. Chen X. Lu Y. Chen T. Li R. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021;7:11.
  4. Koullali B, Oudijk MA, Nijman TA, Mol BW, Pajkrt E. Risk assessment and management to prevent preterm birth. Semin Fetal Neonatal Med. 2016;21:80–8.
  5. Pytka M, Kordowska-Wiater M, Jarocki P. Mikrobiom układu płciowego kobiet. Post Mikrobiol. 2017;58:227–36.
  6. Binek M. Mikrobiom człowieka - zdrowie i choroba, Post Mikrobiol. 2012;51:27–36.
  7. Grewal K, MacIntyre DA, Bennett PR. The reproductive tract microbiota in pregnancy. Biosci Rep. 2021;41:BSR20203908.
  8. De Seta F, Campisciano G, Zanotta N, Ricci G, Comar M. The Vaginal Community State Types Microbiome-Immune Network as Key Factor for Bacterial Vaginosis and Aerobic Vaginitis. Front Microbiol. 2019;10:2451.
  9. Chee WJY, Chew SY, Than LTL. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Fact. 2020;19:203.
  10. France MT, Ma B, Gajer P, Brown S, Humphrys MS, Holm JB, Waetjen LE, Brotman RM, Ravel J. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8:166.
  11. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. Vaginal microbiome of reproductiveage women. Proc Natl Acad Sci USA. 2011;108:4680–7.
  12. Freitas AC, Hill JE. Quantification, isolation and characterization of Bifidobacterium from the vaginal microbiomes of reproductive aged women. Anaerobe. 2017;47:145–156.
  13. Bradford LL, Ravel J. The vaginal mycobiome: A contemporary perspective on fungi in women’s health and diseases. Virulence. 2017;8:342–51.
  14. Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG. 2015;122:785–94.
  15. O’Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One. 2013;8:e80074.
  16. Linhares IM, Summers PR, Larsen B, Giraldo PC, Witkin SS. Contemporary perspectives on vaginal pH and lactobacilli. Am J Obstet Gynecol. 2011;204:120.e1–5.
  17. Bull M, Plummer S, Marchesi J, Mahenthiralingam E. The life history of Lactobacillus acidophilus as a probiotic: a tale of revisionary taxonomy, misidentification and commercial success. FEMS Microbiol Lett. 2013;349:77–87.
  18. George F, Daniel C, Thomas M, Singer E, Guilbaud A, Tessier JF, Revol-Junelles AM, Borges F, Foligne B. Occurrence and dynamism of lactic acid bacteria in distinct ecological niches: A multifaceted functional health perspective. Front Microbiol. 2018;9:2899.
  19. Zotta T, Parente E, Ricciardi A. Aerobic metabolism in the genus Lactobacillus: impact on stress response and potential applications in the food industry. J Appl Microbiol. 2017;122:857–69.
  20. Klaenhammer TR. Bacteriocins of lactic acid bacteria. Biochimie. 1988;70:337–49.
  21. Abou Chacra L, Fenollar F, Diop K. Bacterial Vaginosis: What Do We Currently Know? Front Cell Infect Microbiol. 2022;11:672429.
  22. Gregoire AT, Kandil O, Ledger WJ. The glycogen content of human vaginal epithelial tissue. Fertil Steril. 1971;22:64–8.
  23. Bagga R, Arora P. Genital Micro-Organisms in Pregnancy. Front Public Health. 2020;8:225.
  24. McLaughlin SE, Ghanem KG, Zenilman JM, Griffiss JM. Risk of Gonococcal Infection During Vaginal Exposure is Associated With High Vaginal pH and Active Menstruation. Sex Transm Dis., 2019;46:86–90.
  25. Panda S, Das A, Singh AS, Pala S. Vaginal pH: A marker for menopause. J Midlife Health. 2014;5:34–7.
  26. Loveless M, Myint O. Vulvovaginitis-presentation of more common problems in pediatric and adolescent gynecology. Best Pract Res Clin Obstet Gynaecol. 2018;48:14–27.
  27. Wagner G, Ottesen B. Vaginal physiology during menstruation. Ann Intern Med. 1982;96:921–3.
  28. Niziurski P, Adamczyk-Gruszka O, Gruszka J. Ocena przydatności samokontroli pH wydzieliny pochwowej przez kobiety ciężarne we wczesnym wykrywaniu bakteryjnego zakażenia pochwy. Studia medyczne. 2012;26:49–53.
  29. Malarewicz A, Szymkiewicz J, Sola M, Błaszczak M. pH środowiska pochwy i mikroskopia fazowo-kontrastowa rozmazów cytologicznych u kobiet po menopauzie. Przegląd Menopauzalny, 2011;3:222–7.
  30. Nalewczyńska A, Cendrowska A, Kowalska J, et al. Zaburzenia biocenozy pochwy–postępowanie diagnostyczne oraz leczenie. Ginekol Prakt. 2009;3:33–369.
  31. Domagalska B. Kosmetyki do higieny intymnej. Świat przemysłu kosmetycznego. 2020;1:74–7.
  32. Domagalska B. Surfaktanty gemini w wyrobach chemii gospodarczej. Chemia i Biznes. Rynek Kosmetyczny i Chemii Gospodarczej. 2013;3:38–9.
  33. Liu L. Penetration of Surfactants into Skin. J Cosmet Sci. 2020;71:91–109.
  34. Rinaldi G. The Itch-Scratch Cycle: A Review of the Mechanisms. Dermatol Pract Concept. 2019;9:90–7.
  35. Linhares IM, Sisti G, Minis E, de Freitas GB, Moron AF, Witkin SS. Contribution of Epithelial Cells to Defense Mechanisms in the Human Vagina. Curr Infect Dis Rep. 2019;21:30.
  36. Alkhanjaf AAM, Athar MT, Ullah Z, Umar A, Shaikh IA. In Vitro and In Vivo Evaluation of a Nano-Tool Appended Oilmix (Clove and Tea Tree Oil) Thermosensitive Gel for Vaginal Candidiasis. J Funct Biomater. 2022;13:203.
  37. Güçlü-Ustündağ O, Mazza G. Saponins: properties, applications and processing. Crit Rev Food Sci Nutr. 2007;47:231–58.
  38. Yang L, Liu X, Zhuang X, Feng X, Zhong L, Ma T. Antifungal Effects of Saponin Extract from Rhizomes of Dioscorea panthaica Prain et Burk against Candida albicans. Evid Based Complement Alternat Med. 2018;2018:6095307.
  39. Hesham H, Mitchell AJ, Bergerat A, Hung K, Mitchell CM. Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses. Sci Rep. 2021;11:23069.
  40. Frąszczak K, Barczyński B, Kondracka A. Does Lactobacillus Exert a Protective Effect on the Development of Cervical and Endometrial Cancer in Women? Cancers (Basel). 2022;14:4909.
  41. Bruning E, Chen Y, McCue KA, Rubino JR, Wilkinson JE, Brown ADG. A 28 Day Clinical Assessment of a Lactic Acid-containing Antimicrobial Intimate Gel Wash Formulation on Skin Tolerance and Impact on the Vulvar Microbiome. Antibiotics (Basel). 2020;9:55.
  42. van der Veer C, Bruisten SM, van Houdt R, Matser AA, Tachedjian G, van de Wijgert JHHM, de Vries HJC, van der Helm JJ. Effects of an over-the-counter lactic-acid containing intra-vaginal douching product on the vaginal microbiota. BMC Microbiol. 2019;19:168.
  43. Arct J, Depta P. Alantoina – działanie i wykorzystanie kosmetyczne. Pol J Cosmetol. 2016;19:12–17.
  44. Arct J, Pytkowska K. Kosmetyki do pielęgnacji skóry suchej. Cosmetology Today. 2009;3:34–7.
  45. Russell K, Jacob SE. Bisabolol. Dermatitis. 2010;21:57–8.
  46. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. OJ L 342; 59–209.
  47. Natywa M, Górska A. Stosowanie konserwantów w kosmetykachza i przeciw. Kosmetologia Estetyczna. 2015;3:133–7.
  48. Bretelle F, Rozenberg P, Pascal A, Favre R, Bohec C, Loundou A, et al. High Atopobium Vaginae and Gardnerella Vaginalis Vaginal Loads Are Associated with Preterm Birth. Clin Infect Dis. 2015;60:860–7.
  49. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance Clin Microbiol Rev 2001 Jan;14(1):227]. Clin Microbiol Rev. 1999;12:147–79.
  50. Zimmer M, Huras H, Kaminski P, Karowicz-Bilinska A, Drews K, Fuchs T, Pomorski M. Polish Society of Gynecologists and Obstetricians recommendation on the use of antiseptics for treatment of inflammatory vaginitis. Ginekologia Polska. 2020;91:432–7.
  51. Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M, Midulla C. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect. 2009;15:67–74.
  52. Tidbury FD, Langhart A, Weidlinger S, Stute P. Non-antibiotic treatment of bacterial vaginosis: a systematic review. Arch Gynecol Obstet. 2021;303:37–45.
  53. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 2006;8:1450–4.
  54. GG Donders G, Zodzika J, Rezeberga D. Treatment of bacterial vaginosis: what we have and what we miss. Expert Opinion on Pharmacotherapy. 2014;15:645–57.
  55. Khazaeian S, Navidian A, Navabi-Rigi SD, Araban M, Mojab F, Khazaeian S. Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: a randomized controlled trial. Trials. 2018;19:585.
  56. Xiao BB, Zhang D, Chen R, Shi HR, Xin XR, Wang HL, Pang YC, Zhu SN, Yao C, Liao QP. Sucrose gel for treatment of bacterial vaginosis: a randomized, double-blind, multi-center, parallel-group, phase III clinical trial. Beijing Da Xue Xue Bao Yi Xue Ban. 2015;47:925–32.
Language: English
Page range: 37 - 44
Submitted on: Jul 14, 2023
Accepted on: Feb 13, 2024
Published on: Apr 9, 2024
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Justyna Długosz, Natasza Millan, Łukasz Sędek, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.